Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial
Go back to Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 2.05 +0.09 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $8.19 | |||
| Open | $1.95 | 52 Week Low | $3.39 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $0.00 | |||
| Volume | 1,687,172 | |||||
